Nursing care
Trimethoprim-Sulfamethoxazole: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Trimethoprim-sulfamethoxazole nursing care centres on hydration, skin monitoring, and drug interactions. Encourage two to three litres of fluid a day to prevent crystalluria, hold the dose and notify the prescriber if a rash appears, and watch INR closely in patients on warfarin because the combination potentiates its effect.
Why this drug and not another
Trimethoprim-sulfamethoxazole is chosen when the organism is known or strongly suspected to be susceptible and when a cheap, oral, well-absorbed agent will do the job without reaching for broader-spectrum cover. It sits at the centre of empirical therapy for uncomplicated UTI, for Pneumocystis jirovecii pneumonia prophylaxis and treatment in immunocompromised patients, and for certain skin and soft tissue infections where community-acquired MRSA is a concern.
The two components work by blocking sequential steps in bacterial folate synthesis, which is why the combination is bactericidal where either drug alone is only bacteriostatic. That synergy is the clinical reason it gets picked over a single-agent sulfonamide or trimethoprim alone, and it is worth knowing for the exam because questions often test whether you understand combination rationale rather than just brand recognition.
Administration and timing
Give with a full glass of water and encourage two to three litres of fluid intake across the day, spread rather than taken in one sitting. This is the detail that separates safe administration from a false sense of adequacy: sipping through the day protects the renal tubules from crystal formation far better than one large drink at breakfast.
Oral doses are usually given with food to reduce gastrointestinal upset, and the IV formulation, when used for severe infection, is infused slowly over the time stated on the product information to avoid infusion-related reactions. Space doses evenly, typically every 12 hours for standard regimens, and complete the full course even once symptoms settle, since early discontinuation invites relapse and resistance.
Monitoring parameters
Baseline renal function matters because the drug is renally cleared and can itself impair function in dehydrated or elderly patients. Check serum creatinine and electrolytes, particularly potassium, since trimethoprim can cause hyperkalaemia by a mechanism similar to amiloride, an effect that is more pronounced in patients with renal impairment or those on ACE inhibitors.
In patients on long-term therapy, monitor full blood count for bone marrow suppression, since the antifolate effect can cause leukopenia, thrombocytopenia, or megaloblastic changes. Anyone already on warfarin needs INR checked more frequently after starting or stopping this drug, because trimethoprim-sulfamethoxazole displaces warfarin from protein binding and inhibits its metabolism, raising the INR and the bleeding risk.
Adverse effects to report
A rash is a stop, not a watch-and-wait. Any new rash, however mild it looks, should prompt withholding the next dose and notifying the prescriber immediately, because sulfonamide hypersensitivity can progress rapidly to Stevens-Johnson syndrome or toxic epidermal necrolysis. Do not reassure a patient that a rash is likely minor; escalate first.
Report fever, sore throat, unusual bruising or bleeding, and jaundice, all of which can signal blood dyscrasias or hepatotoxicity. Nausea and vomiting are common and usually tolerable with food, but persistent vomiting, signs of dehydration, or a marked drop in urine output should also be reported, since they compound the crystalluria risk this drug already carries.
Contraindications and cautions
Avoid in patients with a known sulfonamide allergy, in infants under two months, and in pregnancy near term, since sulfamethoxazole can displace bilirubin and contribute to kernicterus. Use with caution in folate deficiency, megaloblastic anaemia, and severe renal impairment, where clearance is reduced and toxicity accumulates.
Caution is also needed in patients taking warfarin, methotrexate, phenytoin, or ACE inhibitors, since trimethoprim-sulfamethoxazole interacts with all of them through protein-binding displacement, folate antagonism, or additive hyperkalaemia. G6PD deficiency raises the risk of haemolytic anaemia with sulfonamides, so screen when the history suggests it.
Teaching points the exam tests
Expect a question that pairs this drug with warfarin and asks what to monitor: the answer is INR, because the interaction raises anticoagulant effect and bleeding risk. Expect another that gives a patient a new rash on day four and asks for the priority action: withhold the dose and notify the provider, not simply document and reassess in 24 hours.
The fluid teaching point is tested as a specific volume, not a vague instruction to drink more. Two to three litres a day, taken throughout the day, is the number to know, and it exists specifically to prevent crystalluria in the renal tubules. Sun sensitivity, the need to avoid direct sunlight or use sunscreen, and finishing the full course are the other teaching points that show up repeatedly.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Why does trimethoprim-sulfamethoxazole raise INR in patients on warfarin?
It displaces warfarin from plasma protein binding and inhibits its hepatic metabolism, increasing the free, active concentration of warfarin. This raises the INR and the bleeding risk, so INR should be checked soon after starting the antibiotic and again after it is stopped.
What should a nurse do if a patient develops a rash while on this drug?
Withhold the next dose and notify the prescriber immediately rather than waiting to see if it worsens. Sulfonamide hypersensitivity can progress quickly to serious skin reactions, so a rash is treated as a stop signal, not a minor side effect to monitor.
How much fluid should a patient drink while taking this medication?
Two to three litres a day, spread across the day rather than taken all at once. Adequate hydration reduces the risk of crystals forming in the renal tubules, which is one of the drug's more serious potential adverse effects.
Is trimethoprim-sulfamethoxazole safe in pregnancy?
It is generally avoided, particularly near term, because sulfamethoxazole can displace bilirubin from albumin and increase the risk of kernicterus in the neonate. Use in pregnancy depends on trimester, indication, and alternatives, and should follow current facility and prescriber guidance.
What lab values should be monitored during long-term therapy?
Renal function, serum potassium, and full blood count should be checked periodically. The drug can cause hyperkalaemia through a potassium-sparing-like effect and can suppress bone marrow function through its antifolate action, so both need surveillance beyond the initial course.
More on pharmacology
Guides on this